NH2-truncated tau fragments of 20–22 kDa have been identified as CSF biomarkers of neurodegenerative diseases and have also been found in mitochondria extracted from cryopreserved synaptosomes (Amadoro et al., 2014;, 2020). Here, MAPT is linked to neurodegenerative disease.